Skip to main content

Table 1 Demographic date, clinical data, frequency of symptoms, and clinical signs

From: Safety of spinal anesthesia and analysis of cerebrospinal fluid in SARS-CoV-2 pregnant women undergoing cesarean section: an observational prospective study

Demographic data

Age (mean; SD)

32.8; 2.99

BMI (mean; SD)

32.8; 9.18

Parity (n; %)

Multiparous: 3 (11.5)

Nulliparous: 23 (88.5)

Vaccinated (n; %)

8 (30.7)

Symptoms at the time of CS

Frequency (n; %)

None

16 (61.5)

Fever

7 (26.9)

Headache

1 (3.8)

Anosmia

3 (11.5)

Dysgeusia

3 (11.5)

Rhinorrhea

2 (7.7)

Cough

3 (11.5)

Diarrhea

1 (3.8)

Ground-glass opacity (GGO) at CXR

2 (7.7)

  1. The total percentage is more than 100% as patients could have more than one symptom
  2. SD Standard deviation, BMI Body mass index, CS Cesarean section, CXR Chest radiography